Sharesmagazine
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Share Price   Awards   Market Scan   Videos   Broker Notes   Director Deals   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Indices   Forward Diary   Forex Prices   Shares Magazine   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Comparison Tables   Spread Betting 
You are NOT currently logged in
Register now or login to post to this thread.

CANCER drug co. Oxford Biomedica charts (OXB)     

apple - 25 Mar 2004 20:47

Chart.aspx?Provider=EODIntra&Code=OXB&Sidraw?scheme=Colourful&size=Medium&showVodraw?scheme=Colourful&showVolume=true&stdraw?scheme=Colourful&size=Medium&showVoChart.aspx?Provider=EODIntra&Code=OXB&SiChart.aspx?Provider=EODIntra&Code=OXB&Sidraw?scheme=Designer&size=Big&showVolumedraw?scheme=Designer&size=Big&showVolume


OK so you thought the title of the other thread was out of date BUT unfortunately there is no way to edit thread titles.

So here is a new title

This one has got the charts at the top again & has a link to the old one.
http://www.moneyam.com/InvestorsRoom/posts.php?tid=5021


Oakapples142 - 02 Jun 2004 12:36 - 52 of 1451


throoking66 - I very much agree with all you say and rather particularly your last sentence. I am in for the long run.

Janus - 02 Jun 2004 20:59 - 53 of 1451

Great find from Gerry2 from the other place
http://www.newscientist.com/news/news.jsp?id=ns99995067

Janus - 07 Jun 2004 12:47 - 54 of 1451

OXFORD BIOMEDICA ACQUIRES CHIRON PATENTS AND
ISSUES SHARES TO CHIRON


Oxford, UK - 7 June 2004: Oxford BioMedica (LSE OXB), the leading gene therapy
company, announced today that it has signed an agreement with the Chiron
Corporation to acquire certain patent families from Chiron's gene therapy patent
portfolio. The agreement includes taking assignment of Chiron's interest in a
license agreement with an undisclosed university. Financial terms have not been
disclosed.

Chiron's patent portfolio contains some early gene therapy technology that
complements Oxford BioMedica's substantial gene therapy patent estate. The
technology acquired includes:

1. The use of human cell lines for the production of gene therapy products

2. Gene-directed enzyme pro-drug therapy (GDEPT)

3. The use of the envelope protein of the vesicular stomatis virus (VSV-g) for
increasing the ability of gene therapy vectors to transduce a broad range
of human cell types

Under a separate agreement also signed today, Chiron has made an equity
investment in Oxford BioMedica subscribing for a total of 316,026 ordinary
shares of 1p each at 17.23 pence per share.

Commenting on these agreements the Company's Senior Vice President for
Commercial Development, Peter Nolan, said: 'We are delighted to have concluded
this agreement with Chiron and welcome them as shareholders in the Company.
Securing this intellectual property will enhance our competitive position in
gene therapy and in the use of our technology in drug discovery.'


-Ends-

http://www.uk-wire.com/cgi-bin/articles/200406071239294760z.html

apple - 07 Jun 2004 12:54 - 55 of 1451

Thanks Janus

Tokyo - 17 Jun 2004 22:39 - 56 of 1451

http://www.oxfordbiomedica.co.uk/news/2004-ob-11.htm

another grant, just the bit of good news needed for this stock

apple - 02 Jul 2004 12:47 - 57 of 1451

Down again,

A little bit lower & I'll buy some more.

apple - 05 Jul 2004 10:42 - 58 of 1451


05/07/04 09:00 Oxford Biomedica in licence deal with Viragen for LentiVector gene delivery AFX

Oxford Biomedica in licence deal with Viragen for LentiVector gene delivery
AFX

LONDON (AFX) - Oxford Biomedica PLC said it has entered into a licence agreement with Viragen Inc for its LentiVector gene delivery technology.

The agreement provides Viragen with worldwide exclusive rights to utilize the proprietary LentiVector technology in its collaboration with Roslin Institute (Scotland) to develop Avian Transgenic Technology as a novel platform for the efficient and economical manufacturing of therapeutic proteins in chicken eggs.

Under the agreement, Oxford BioMedica will receive an upfront licence fee and annual maintenance payments, the statement added.

In addition, Oxford BioMedica will receive milestone payments on the achievement of technical goals by Viragen and royalties on commercialisation of the Avian Transgenic Technology.

No other financial details were provided.

newsdesk@afxnews.com

http://www.moneyam.com/action/news/showArticle?id=389728

dunbarton - 05 Jul 2004 11:15 - 59 of 1451

Testing resistance at 20p, needs more volumes to get through that and then it's 23 then 25.

apple - 05 Jul 2004 22:51 - 60 of 1451

Where next?

Back to 30 I hope.

Lots of small caps seem to be recovering.

robstuff - 24 Jul 2004 12:22 - 61 of 1451

Time to buy again, more news to come soon and these will motor again, there's hardly any risk buying at 16p - the foundations have been laid and the fair value is nearer 35p, the graph shows 16 as the resistance and that level will rise with added value from license deals and positive newsflow, this share really is undervalued at this price. Still confident 2 in next 3yrs.

Riviera - 25 Jul 2004 23:56 - 62 of 1451

apple - 26 Jul 2004 13:35 - 63 of 1451

robstuff

Yep, it is a good time.

apple - 26 Jul 2004 16:04 - 64 of 1451

The buyers are back today so I joined them.

apple - 27 Jul 2004 10:19 - 65 of 1451

On the up again!

hlyeo98 - 04 Aug 2004 12:24 - 66 of 1451

Hardly moving - boring at 16p

Oakapples142 - 26 Aug 2004 15:43 - 67 of 1451


Hello whats brought this on to-day (nicely jumped into the blue) let us hope that there has been a little leak of good news to come.

Janus - 26 Aug 2004 16:04 - 68 of 1451

Intrims and analyst briefing next Wed, good news maybe !

The results will be on web cast too for those who wish to watch

http://www.oxfordbiomedica.co.uk

apple - 26 Aug 2004 17:13 - 69 of 1451

What a nice rise, I sold out at 18p a while back but bought some again at the end of last month & decided to get back in substantially when it hit 14.5p.

Except for last month, I accidently seem to keep getting my timing just right with OXB :-)

Oakapples142 - 27 Aug 2004 09:16 - 70 of 1451


It just might keep going blue prior to next Wednesday if and when good news should see it return to 25p -

apple - 27 Aug 2004 16:06 - 71 of 1451

Another nice rise today but not a great number of buyers to cause it.

Register now or login to post to this thread.